Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease (Q34158521)

31 July 2017

Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease (English)

1 reference

31 July 2017

0 references

1 reference

7

Mark T Gladwin

1 reference

31 July 2017

5

Richard O Cannon

1 reference

31 July 2017

Christopher D Reiter

1

1 reference

31 July 2017

Xunde Wang

2

1 reference

31 July 2017

Jose E Tanus-Santos

3

1 reference

31 July 2017

Neil Hogg

4

1 reference

31 July 2017

Alan N Schechter

6

1 reference

31 July 2017

language of work or name

English

0 references

publication date

11 November 2002

1 reference

31 July 2017

1 reference

31 July 2017

8

1 reference

31 July 2017

1383-1389

1 reference

31 July 2017

12

1 reference

https://scigraph.springernature.com/pub.10.1038/nm1202-799

31 July 2017

0 references

cites work

Mechanism of NO-induced oxidation of myoglobin and hemoglobin

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-799

7 January 2021

Kinetic and mechanistic studies of the NO*-mediated oxidation of oxymyoglobin and oxyhemoglobin

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-799

7 January 2021

The kinetics and equilibria of the reactions of nitric oxide with sheep haemoglobin.

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-799

7 January 2021

Conformation, co-operativity and ligand binding in human hemoglobin

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-799

7 January 2021

The rate of uptake of carbon monoxide and of nitric oxide by normal human erythrocytes and experimentally produced spherocytes

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-799

7 January 2021

Diffusion-limited reaction of free nitric oxide with erythrocytes.

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-799

7 January 2021

A tutorial on the diffusibility and reactivity of free nitric oxide.

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-799

7 January 2021

Systemic and pulmonary hypertension after resuscitation with cell-free hemoglobin

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-799

7 January 2021

Limitations of the efficacy of hemoglobin-based oxygen-carrying solutions.

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-799

7 January 2021

Pulmonary hypertension and systemic vasoconstriction may offset the benefits of acellular hemoglobin blood substitutes.

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-799

7 January 2021

Regional blood flow alterations after bovine fumaryl beta beta-crosslinked hemoglobin transfusion and nitric oxide synthase inhibition

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-799

7 January 2021

The effects of recombinant human hemoglobin on esophageal motor functions in humans.

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-799

7 January 2021

Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled efficacy trial

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-799

7 January 2021

Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin.

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-799

7 January 2021

Erythrocytes possess an intrinsic barrier to nitric oxide consumption.

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-799

7 January 2021

Modulation of nitric oxide bioavailability by erythrocytes

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-799

7 January 2021

Diffusion of nitric oxide and scavenging by blood in the vasculature

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-799

7 January 2021

Intravascular flow decreases erythrocyte consumption of nitric oxide.

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-799

7 January 2021

The molecular pathobiology of cell membrane iron: the sickle red cell as a model

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-799

7 January 2021

Accelerated autoxidation and heme loss due to instability of sickle hemoglobin

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-799

7 January 2021

Plasma Hemoglobin and Hemoglobin Fractions in Sickle Cell Crisis

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-799

7 January 2021

Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-799

7 January 2021

Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-799

7 January 2021

Nitric oxide reaction with red blood cells and hemoglobin under heterogeneous conditions

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-799

7 January 2021

Autoxidation kinetics of aqueous nitric oxide

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-799

7 January 2021

The biochemistry and physiology of S-nitrosothiols

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-799

7 January 2021

Role of circulating nitrite and S-nitrosohemoglobin in the regulation of regional blood flow in humans

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-799

7 January 2021

Relative role of heme nitrosylation and beta-cysteine 93 nitrosation in the transport and metabolism of nitric oxide by hemoglobin in the human circulation

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-799

7 January 2021

Nitric oxide in the human respiratory cycle.

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-799

7 January 2021

Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-799

7 January 2021

Exposure of endothelial cells to recombinant human erythropoietin induces nitric oxide synthase activity

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-799

7 January 2021

Identification of the haemoglobin scavenger receptor.

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-799

7 January 2021

Endothelial dysfunction in patients with sickle cell disease is related to selective impairment of shear stress-mediated vasodilation

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-799

7 January 2021

Mechanisms of vascular instability in a transgenic mouse model of sickle cell disease

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-799

7 January 2021

Impaired nitric oxide-mediated vasodilation in transgenic sickle mouse

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-799

7 January 2021

Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-799

7 January 2021

Evidence for in vivo transport of bioactive nitric oxide in human plasma.

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-799

7 January 2021

Arginine therapy: a novel strategy to induce nitric oxide production in sickle cell disease

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-799

7 January 2021

Inhaled nitric oxide augments nitric oxide transport on sickle cell hemoglobin without affecting oxygen affinity

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-799

7 January 2021

A chemiluminescense-based assay for S-nitrosoalbumin and other plasma S-nitrosothiols

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-799

7 January 2021

S-Nitrosohemoglobin is unstable in the reductive erythrocyte environment and lacks O2/NO-linked allosteric function.

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-799

7 January 2021

Identifiers

DOI

10.1038/NM1202-799

1 reference

31 July 2017

1 reference